76 related articles for article (PubMed ID: 10320365)
1. Rational design of alpha-keto triglyceride analogues as inhibitors for Staphylococcus hyicus lipase.
Simons JW; Cox RC; Egmond MR; Verheij HM
Biochemistry; 1999 May; 38(19):6346-51. PubMed ID: 10320365
[TBL] [Abstract][Full Text] [Related]
2. Sterically hindered triacylglycerol analogues as potent inhibitors of human digestive lipases.
Constantinou-Kokotou V; Magrioti V; Verger R
Chemistry; 2004 Mar; 10(5):1133-40. PubMed ID: 15007804
[TBL] [Abstract][Full Text] [Related]
3. Phosphonate analogues of triacylglycerols are potent inhibitors of lipase.
Mannesse ML; Boots JW; Dijkman R; Slotboom AJ; van der Hijden HT; Egmond MR; Verheij HM; de Haas GH
Biochim Biophys Acta; 1995 Oct; 1259(1):56-64. PubMed ID: 7492616
[TBL] [Abstract][Full Text] [Related]
4. Structure-reactivity relationships for the inhibition mechanism at the second alkyl-chain-binding site of cholesterol esterase and lipase.
Lin G; Shieh CT; Ho HC; Chouhwang JY; Lin WY; Lu CP
Biochemistry; 1999 Aug; 38(31):9971-81. PubMed ID: 10433704
[TBL] [Abstract][Full Text] [Related]
5. Novel trifluoromethyl ketones as potent gastric lipase inhibitors.
Kokotos G; Kotsovolou S; Verger R
Chembiochem; 2003 Jan; 4(1):90-5. PubMed ID: 12512081
[TBL] [Abstract][Full Text] [Related]
6. Triacylglycerols based on 2-(N-tert-butoxycarbonylamino)oleic acid are potent inhibitors of pancreatic lipase.
Magrioti V; Verger R; Constantinou-Kokotou V
J Med Chem; 2004 Jan; 47(2):288-91. PubMed ID: 14711301
[TBL] [Abstract][Full Text] [Related]
7. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
8. Modifying the substrate specificity of staphylococcal lipases.
van Kampen MD; Verheij HM; Egmond MR
Biochemistry; 1999 Jul; 38(29):9524-32. PubMed ID: 10413530
[TBL] [Abstract][Full Text] [Related]
9. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of dog and human gastric lipases by enantiomeric phosphonate inhibitors: a structure-activity study.
Miled N; Roussel A; Bussetta C; Berti-Dupuis L; Rivière M; Buono G; Verger R; Cambillau C; Canaan S
Biochemistry; 2003 Oct; 42(40):11587-93. PubMed ID: 14529268
[TBL] [Abstract][Full Text] [Related]
11. Structural basis of phospholipase activity of Staphylococcus hyicus lipase.
Tiesinga JJ; van Pouderoyen G; Nardini M; Ransac S; Dijkstra BW
J Mol Biol; 2007 Aug; 371(2):447-56. PubMed ID: 17582438
[TBL] [Abstract][Full Text] [Related]
12. Bis-2-oxo amide triacylglycerol analogues: a novel class of potent human gastric lipase inhibitors.
Kotsovolou S; Chiou A; Verger R; Kokotos G
J Org Chem; 2001 Feb; 66(3):962-7. PubMed ID: 11430119
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of 2-Oxo amide triacylglycerol analogues and study of their inhibition effect on pancreatic and gastric lipases.
Kokotos G; Verger R; Chiou A
Chemistry; 2000 Nov; 6(22):4211-7. PubMed ID: 11128286
[TBL] [Abstract][Full Text] [Related]
14. Fluorescent inhibitors for the qualitative and quantitative analysis of lipolytic enzymes.
Scholze H; Stütz H; Paltauf F; Hermetter A
Anal Biochem; 1999 Dec; 276(1):72-80. PubMed ID: 10585746
[TBL] [Abstract][Full Text] [Related]
15. Ortho effects for inhibition mechanisms of butyrylcholinesterase by o-substituted phenyl N-butyl carbamates and comparison with acetylcholinesterase, cholesterol esterase, and lipase.
Lin G; Lee YR; Liu YC; Wu YG
Chem Res Toxicol; 2005 Jul; 18(7):1124-31. PubMed ID: 16022504
[TBL] [Abstract][Full Text] [Related]
16. Purification and substrate specificity of Staphylococcus hyicus lipase.
van Oort MG; Deveer AM; Dijkman R; Tjeenk ML; Verheij HM; de Haas GH; Wenzig E; Götz F
Biochemistry; 1989 Nov; 28(24):9278-85. PubMed ID: 2611229
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of gamma-phosphono diester analogues of glutamate as highly potent inhibitors and active site probes of gamma-glutamyl transpeptidase.
Han L; Hiratake J; Kamiyama A; Sakata K
Biochemistry; 2007 Feb; 46(5):1432-47. PubMed ID: 17260973
[TBL] [Abstract][Full Text] [Related]
18. Sesquiterpene farnesol as a competitive inhibitor of lipase activity of Staphylococcus aureus.
Kuroda M; Nagasaki S; Ito R; Ohta T
FEMS Microbiol Lett; 2007 Aug; 273(1):28-34. PubMed ID: 17559400
[TBL] [Abstract][Full Text] [Related]
19. Enzyme inhibitors as chemical tools to study enzyme catalysis: rational design, synthesis, and applications.
Hiratake J
Chem Rec; 2005; 5(4):209-28. PubMed ID: 16041744
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of the surface-associated lipase of Staphylococcus saprophyticus.
Sakinç T; Kleine B; Gatermann SG
FEMS Microbiol Lett; 2007 Sep; 274(2):335-41. PubMed ID: 17645523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
